Stay updated on Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number has been updated from v3.5.2 to v3.5.3, indicating a tooling or platform update rather than a change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:14.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:38:01.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision badge updated to v3.5.0; previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T05:57:49.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:40:09.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2; previous notices including v3.4.1 and funding/operational status messages have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:22:27.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Added a notice about potential data delays due to a funding lapse. Updated site revision tag from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:37:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Unresectable Squamous Skin Cancer Clinical Trial page.